This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, S.
Right arrow Articles by Kawaoka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, S.
Right arrow Articles by Kawaoka, Y.

 Previous Article  |  Next Article 

Journal of Virology, January 2004, p. 999-1005, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.999-1005.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics

Shinji Watanabe,1 Tokiko Watanabe,2,3 Takeshi Noda,2,4 Ayato Takada,2,3 Heinz Feldmann,5 Luke D. Jasenosky,1 and Yoshihiro Kawaoka1,2,3*

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin—Madison, Madison, Wisconsin 53706,1 Institute of Medical Science, University of Tokyo, Tokyo 108-8639,2 CREST, Japan Science and Technology Corporation, Saitama 332-0012,3 Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan,4 Special Pathogen Program, National Microbiology Laboratory, Canadian Science Centre for Human and Animal Health, Winnipeg, Manitoba R3E 3R2, Canada5

Received 14 July 2003/ Accepted 26 September 2003

We established a plasmid-based system for generating infectious Ebola virus-like particles (VLPs), which contain an Ebola virus-like minigenome consisting of a negative-sense copy of the green fluorescent protein gene. This system produced nearly 103 infectious particles per ml of supernatant, equivalent to the titer of Ebola virus generated by a reverse genetics system. Interestingly, infectious Ebola VLPs were generated, even without expression of VP24. Transmission and scanning electron microscopic analyses showed that the morphology of the Ebola VLPs was indistinguishable from that of authentic Ebola virus. Thus, this system allows us to study Ebola virus entry, replication, and assembly without biosafety level 4 containment. Furthermore, it may be useful in vaccine production against this highly pathogenic agent.


* Corresponding author. Mailing address: Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin—Madison, 2015 Linden Dr., Madison, WI 53706. Phone: (608) 265-4925. Fax: (608) 265-5622. E-mail: kawaokay{at}svm.vetmed.wisc.edu.


Journal of Virology, January 2004, p. 999-1005, Vol. 78, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.2.999-1005.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Enterlein, S., Schmidt, K. M., Schumann, M., Conrad, D., Krahling, V., Olejnik, J., Muhlberger, E. (2009). The Marburg Virus 3' Noncoding Region Structurally and Functionally Differs from That of Ebola Virus. J. Virol. 83: 4508-4519 [Abstract] [Full Text]  
  • Kobayashi, T., Ooms, L. S., Chappell, J. D., Dermody, T. S. (2009). Identification of Functional Domains in Reovirus Replication Proteins {micro}NS and {micro}2. J. Virol. 83: 2892-2906 [Abstract] [Full Text]  
  • Rennick, L. J., Duprex, W. P., Rima, B. K. (2007). Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J. Gen. Virol. 88: 2710-2718 [Abstract] [Full Text]  
  • Noda, T., Watanabe, S., Sagara, H., Kawaoka, Y. (2007). Mapping of the VP40-Binding Regions of the Nucleoprotein of Ebola Virus. J. Virol. 81: 3554-3562 [Abstract] [Full Text]  
  • Hartlieb, B., Muziol, T., Weissenhorn, W., Becker, S. (2007). Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc. Natl. Acad. Sci. USA 104: 624-629 [Abstract] [Full Text]  
  • Overby, A. K., Popov, V., Neve, E. P. A., Pettersson, R. F. (2006). Generation and Analysis of Infectious Virus-Like Particles of Uukuniemi Virus (Bunyaviridae): a Useful System for Studying Bunyaviral Packaging and Budding. J. Virol. 80: 10428-10435 [Abstract] [Full Text]  
  • Hoenen, T., Groseth, A., Kolesnikova, L., Theriault, S., Ebihara, H., Hartlieb, B., Bamberg, S., Feldmann, H., Stroher, U., Becker, S. (2006). Infection of Naive Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24. J. Virol. 80: 7260-7264 [Abstract] [Full Text]  
  • Hartman, A. L., Dover, J. E., Towner, J. S., Nichol, S. T. (2006). Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication.. J. Virol. 80: 6430-6440 [Abstract] [Full Text]  
  • Johnson, R. F., McCarthy, S. E., Godlewski, P. J., Harty, R. N. (2006). Ebola Virus VP35-VP40 Interaction Is Sufficient for Packaging 3E-5E Minigenome RNA into Virus-Like Particles.. J. Virol. 80: 5135-5144 [Abstract] [Full Text]  
  • Reid, St. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., Basler, C. F. (2006). Ebola Virus VP24 Binds Karyopherin {alpha}1 and Blocks STAT1 Nuclear Accumulation.. J. Virol. 80: 5156-5167 [Abstract] [Full Text]  
  • Watanabe, S., Noda, T., Kawaoka, Y. (2006). Functional mapping of the nucleoprotein of ebola virus.. J. Virol. 80: 3743-3751 [Abstract] [Full Text]  
  • Wang, D., Raja, N. U., Trubey, C. M., Juompan, L. Y., Luo, M., Woraratanadharm, J., Deitz, S. B., Yu, H., Swain, B. M., Moore, K. M., Pratt, W. D., Hart, M. K., Dong, J. Y. (2006). Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus. J. Virol. 80: 2738-2746 [Abstract] [Full Text]  
  • Bamberg, S., Kolesnikova, L., Moller, P., Klenk, H.-D., Becker, S. (2005). VP24 of Marburg Virus Influences Formation of Infectious Particles. J. Virol. 79: 13421-13433 [Abstract] [Full Text]  
  • Neumann, G., Ebihara, H., Takada, A., Noda, T., Kobasa, D., Jasenosky, L. D., Watanabe, S., Kim, J. H., Feldmann, H., Kawaoka, Y. (2005). Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture. J. Virol. 79: 10300-10307 [Abstract] [Full Text]  
  • Warfield, K. L., Olinger, G., Deal, E. M., Swenson, D. L., Bailey, M., Negley, D. L., Hart, M. K., Bavari, S. (2005). Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection. J. Immunol. 175: 1184-1191 [Abstract] [Full Text]  
  • Wahl-Jensen, V., Kurz, S. K., Hazelton, P. R., Schnittler, H.-J., Stroher, U., Burton, D. R., Feldmann, H. (2005). Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in Activation of Human Macrophages. J. Virol. 79: 2413-2419 [Abstract] [Full Text]  
  • Scholle, F., Girard, Y. A., Zhao, Q., Higgs, S., Mason, P. W. (2004). trans-Packaged West Nile Virus-Like Particles: Infectious Properties In Vitro and in Infected Mosquito Vectors. J. Virol. 78: 11605-11614 [Abstract] [Full Text]